Relivo Formulation Private Limited

Relivo Formulation Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U85121DL2006PTC151718 Incorporated 07 August 2006 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma
Data last updated
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
20 yrs
Est. 2006
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data
Registrar
Delhi
ROC office

About Relivo Formulation Private Limited

Data last updated:

Relivo Formulation Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 August 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85121DL2006PTC151718.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sangeeta Billa and Arvind Billa.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at N – 101 Anupam Apartments East Arjun Nagar, Delhi, India – 110032.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Relivo Formulation Private Limited
CIN U85121DL2006PTC151718
Registration Number 151718
Incorporation Date 07 August 2006
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Sangeeta Billa Director Arvind Billa Director Arvind Kumar Nagpal Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    N – 101 Anupam Apartments East Arjun Nagar, Delhi, India – 110032
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Relivo Formulation Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Relivo Formulation Private Limited report

Financials, compliance, directors, charges, ownership and filings for Relivo Formulation Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Financials of Relivo Formulation Private Limited FY 2025 filings available

Financial Statement Summary of Relivo Formulation Private Limited

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA••••••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)••••••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Relivo Formulation Private Limited

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin••••••••••••••••••••
Net Profit Margin••••••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Relivo Formulation are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Relivo Formulation Private Limited

Relivo Formulation has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sangeeta Billa
Also directs: Affy Pharma Private Limited, Affy Parenterals Private Limited, Affy Hygiene Private Limited and 5 more
Director07 Aug 200620 Years 2 MonthsCurrent
Arvind Billa
Also directs: Affy Pharma Private Limited, Affy Parenterals Private Limited, Affy Hygiene Private Limited and 5 more
Director07 Aug 200620 Years 2 MonthsCurrent
Arvind Kumar NagpalDirector18 Aug 201115 Years 2 MonthsCurrent
View all directors

Auditor Details of Relivo Formulation Private Limited

Relivo Formulation Private Limited is audited by RAJESH PREM & ASSOCIATES for the financial year 2021.

NameStatusAppointment DateCessation Date
RAJESH PREM & ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Relivo Formulation Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Relivo Formulation Private Limited

Relivo Formulation Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Relivo Formulation Private Limited

Employment history and EPFO contributions of people linked to Relivo Formulation.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Relivo Formulation Private Limited

Relivo Formulation Private Limited has 3 board changes on record since 2006: 3 appointments. The latest: Arvind Kumar Nagpal was appointed as Director on 18 Aug 2011.

AGM
Relivo Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Relivo Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Arvind Kumar Nagpal was appointed as Director.
Appointed
Arvind Billa was appointed as Director.
Appointed
Sangeeta Billa was appointed as Director.
Incorporation
07 Aug 2006
Relivo Formulation Private Limited was registered on 07 Aug 2006 with Roc Delhi I & aged 20 years 2 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Relivo Formulation Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Relivo Formulation Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Relivo Formulation Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Relivo Formulation Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Relivo Formulation Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Relivo Formulation Private Limited

Relivo Formulation is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 August 2006 (20+ years old) and is registered under CIN U85121DL2006PTC151718.

Relivo Formulation has 3 current directors:

The CIN (Corporate Identification Number) of Relivo Formulation is U85121DL2006PTC151718. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Relivo Formulation was incorporated on 07 August 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.

Arvind Kumar Nagpal was appointed as Director on 18 Aug 2011. Arvind Billa was appointed as Director on 07 Aug 2006. Sangeeta Billa was appointed as Director on 07 Aug 2006.

The registered office of Relivo Formulation is at N – 101 Anupam Apartments East Arjun Nagar, Delhi, India – 110032.

Relivo Formulation has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.

Relivo Formulation operates in the pharma industry, in the drug formulation and development segment.

No. Relivo Formulation is not listed on any stock exchange. It is an unlisted company.

The compliance status of Relivo Formulation is compliant as of 16 July 2026. The company is actively filing with the Registrar of Companies.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available